Nisa Investment Advisors LLC Boosts Stock Holdings in Definitive Healthcare Corp. (NASDAQ:DH)

Nisa Investment Advisors LLC boosted its stake in Definitive Healthcare Corp. (NASDAQ:DH) by 3,652.7% during the 4th quarter, Holdings Channel reports. The firm owned 6,980 shares of the company’s stock after buying an additional 6,794 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Definitive Healthcare were worth $29,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Point72 DIFC Ltd increased its holdings in shares of Definitive Healthcare by 759.9% in the third quarter. Point72 DIFC Ltd now owns 9,296 shares of the company’s stock worth $42,000 after purchasing an additional 8,215 shares during the last quarter. Intech Investment Management LLC purchased a new position in Definitive Healthcare during the 3rd quarter valued at approximately $55,000. Bleakley Financial Group LLC purchased a new position in Definitive Healthcare during the 3rd quarter valued at approximately $74,000. Glenmede Trust Co. NA increased its stake in Definitive Healthcare by 41.1% in the 3rd quarter. Glenmede Trust Co. NA now owns 18,423 shares of the company’s stock worth $82,000 after acquiring an additional 5,362 shares during the last quarter. Finally, SG Americas Securities LLC purchased a new stake in shares of Definitive Healthcare during the 3rd quarter worth approximately $84,000. Institutional investors own 98.67% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on DH shares. Stephens assumed coverage on shares of Definitive Healthcare in a report on Friday, December 20th. They issued an “equal weight” rating and a $5.00 target price for the company. Needham & Company LLC reissued a “hold” rating on shares of Definitive Healthcare in a research note on Thursday, January 16th. Finally, Barclays restated an “underweight” rating and set a $4.00 target price on shares of Definitive Healthcare in a research report on Monday, January 13th. Two research analysts have rated the stock with a sell rating, six have issued a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, Definitive Healthcare currently has a consensus rating of “Hold” and an average price target of $5.72.

Insider Activity at Definitive Healthcare

In other news, insider William Moschella sold 45,000 shares of the firm’s stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $4.70, for a total transaction of $211,500.00. Following the transaction, the insider now directly owns 433,830 shares of the company’s stock, valued at approximately $2,039,001. This trade represents a 9.40 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 14.84% of the stock is owned by company insiders.

Definitive Healthcare Price Performance

Definitive Healthcare stock opened at $4.86 on Friday. Definitive Healthcare Corp. has a 12-month low of $3.19 and a 12-month high of $10.62. The company has a current ratio of 2.49, a quick ratio of 2.49 and a debt-to-equity ratio of 0.33. The firm has a 50-day moving average price of $4.42 and a 200-day moving average price of $4.45. The firm has a market capitalization of $561.44 million, a PE ratio of -1.57, a price-to-earnings-growth ratio of 3.70 and a beta of 1.41.

Definitive Healthcare (NASDAQ:DH) last announced its quarterly earnings data on Thursday, November 7th. The company reported $0.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.08 by ($0.03). The firm had revenue of $62.70 million during the quarter, compared to the consensus estimate of $61.66 million. Definitive Healthcare had a positive return on equity of 1.76% and a negative net margin of 142.38%. During the same period in the previous year, the business earned $0.01 EPS. As a group, equities research analysts forecast that Definitive Healthcare Corp. will post 0.15 EPS for the current year.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.